Pharmacological enhancement of mGluR5 facilitates contextual fear memory extinction
- 1Genetics Program, Michigan State University, East Lansing, Michigan 48824, USA
- 2Department of Physiology, Michigan State University, East Lansing, Michigan 48824, USA
- 3Neuroscience Program, Michigan State University, East Lansing, Michigan 48824, USA
- Corresponding author: wangho{at}msu.edu
Abstract
Behavioral exposure therapy, which involves extinction of the previously acquired fear, has been used to treat anxiety-related symptoms such as post-traumatic stress disorder. It has been hypothesized that proextinction pharmacotherapeutics may enhance the efficacy of exposure therapy. Systemic administration of the metabotropic glutamate receptor 5 (mGluR5)-positive allosteric modulator 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide (CDPPB) facilitated the extinction of contextual fear memory. Notably, CDPPB also enhanced the initial fear memory formation, and had no effect on memory retrieval. Our data suggest that positive regulation of mGluR5 may offer a new method to enhance exposure therapy through facilitating extinction without adversely affecting other aspects of memory process.
Footnotes
-
[Supplemental material is available for this article.]
-
Article is online at http://www.learnmem.org/cgi/doi/10.1101/lm.035857.114.
- Received May 24, 2014.
- Accepted August 20, 2014.
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first 12 months after the full-issue publication date (see http://learnmem.cshlp.org/site/misc/terms.xhtml). After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.
